Keyphrases
Mexico
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Cervical Dysplasia
100%
US-Mexico Border
100%
Chlamydia Trachomatis
100%
United States
60%
Hybrid Capture
60%
Polymerase Chain Reaction
40%
Enzyme-linked Immunosorbent Assay (ELISA)
40%
Sexually Transmitted Infections
40%
Papillomavirus Infections
40%
Bi-national
40%
Pap Smear
40%
C.trachomatis
40%
High Mortality Rate
20%
Arizona
20%
Two-state
20%
Hispanic
20%
No Significant Difference
20%
Risk Factors
20%
Behavioral Risk Factors
20%
Sonora
20%
Risk Profile
20%
Non-Hispanic
20%
Cervical Cancer
20%
Two-country
20%
Border Region
20%
Northern Mexico
20%
Border Areas
20%
Clinical Measurement
20%
Invasive Cervical Cancer
20%
Quality Control Method
20%
Hybrid Enzymes
20%
United States of America
20%
Mexican Women
20%
Gynecological Care
20%
Chlamydia Trachomatis Infection
20%
Abnormal Cytology
20%
Medicine and Dentistry
Prevalence
100%
Uterine Cervix Dysplasia
100%
Wart Virus
100%
Chlamydia Trachomatis
100%
Polymerase Chain Reaction
50%
Enzyme Linked Immunosorbent Assay
50%
Cervical Cancer
50%
Papanicolaou Stain
50%
Papillomavirus Infection
50%
Mortality Rate
25%
Cross Sectional Study
25%
Cytotechnology
25%
Gynecologic Care
25%
Chlamydia Infection
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Uterine Cervix Dysplasia
100%
Human Papillomavirus
100%
Chlamydia Trachomatis
100%
Immunoassay
50%
Uterine Cervix Cancer
50%
Papillomavirus Infection
50%
Mortality Rate
25%
Cross-Sectional Study
25%
Chlamydiasis
25%
Biochemistry, Genetics and Molecular Biology
Wart Virus
100%
Dysplasia
100%
Chlamydia Trachomatis
100%
Prevalence
80%
Enzyme
40%
Polymerase Chain Reaction
40%
Immunoassay
40%
Mortality Rate
20%
Cross Sectional Study
20%
Quality Control
20%
Immunology and Microbiology
Wart Virus
100%
Chlamydia Trachomatis
100%
Prevalence
80%
Immunoassay
40%
Polymerase Chain Reaction
40%
Mortality Rate
20%
Nursing and Health Professions
Uterine Cervix Dysplasia
100%
Chlamydiasis
25%